zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2022 / Oneness Biotech Co., Ltd. receives a Korean patent on the producing recombinant glycoproteins with modified glycosylation.

Oneness Biotech Co., Ltd. receives a Korean patent on the producing recombinant glycoproteins with modified glycosylation.

2022-02-15

Published Date:2022-02-15

Original Link:https://www.onenessbio.com/en/news_detail142_4.htm

No 1 Date of announcement 2022/02/15 Time of announcement 18:03:08
Subject Oneness Biotech Co., Ltd. receives a Korean patent on the producing recombinant glycoproteins with modified glycosylation.
To which item it meets paragraph 53 Date of events 2022/02/15
Statement
  1. Date of occurrence of the event:2022/02/15
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or   ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:
    The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein , has been granted a Korean patent entitled ” METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION” under the patent number 10-2333923.
  6. Countermeasures:None
  7. Any other matters that need to be specified:None